Tscan therapeutics to participate in the 24th annual needham virtual healthcare conference

Waltham, mass., march 31, 2025 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biotechnology company focused on the development of t cell receptor (tcr)-engineered t cell (tcr-t) therapies for the treatment of patients with cancer, today announced that the company will participate in a fireside chat at the 24th annual needham virtual healthcare conference on monday, april 7, 2025 at 9:30 a.m. eastern time.
TCRX Ratings Summary
TCRX Quant Ranking